ペプチドリームの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2019/07/24 | 5,910 | 5,950 | 5,880 | 5,920 | +40 | +0.7% | 388,200 |
| 2019/07/23 | 5,790 | 5,890 | 5,750 | 5,880 | +100 | +1.7% | 374,600 |
| 2019/07/22 | 5,800 | 5,830 | 5,730 | 5,780 | -100 | -1.7% | 508,700 |
| 2019/07/19 | 5,830 | 5,930 | 5,830 | 5,880 | +110 | +1.9% | 631,500 |
| 2019/07/18 | 5,780 | 5,810 | 5,740 | 5,770 | +40 | +0.7% | 530,200 |
| 2019/07/17 | 5,630 | 5,740 | 5,600 | 5,730 | +20 | +0.4% | 507,700 |
| 2019/07/16 | 5,560 | 5,730 | 5,510 | 5,710 | +120 | +2.1% | 460,000 |
| 2019/07/12 | 5,610 | 5,660 | 5,530 | 5,590 | -40 | -0.7% | 420,200 |
| 2019/07/11 | 5,630 | 5,670 | 5,580 | 5,630 | ±0 | ±0% | 366,400 |
| 2019/07/10 | 5,570 | 5,670 | 5,540 | 5,630 | ±0 | ±0% | 470,300 |
| 2019/07/09 | 5,780 | 5,790 | 5,590 | 5,630 | -80 | -1.4% | 562,500 |
| 2019/07/08 | 5,850 | 5,860 | 5,700 | 5,710 | -210 | -3.5% | 577,500 |
| 2019/07/05 | 5,910 | 5,920 | 5,800 | 5,920 | -10 | -0.2% | 453,000 |
| 2019/07/04 | 5,870 | 5,950 | 5,870 | 5,930 | +130 | +2.2% | 567,200 |
| 2019/07/03 | 5,830 | 5,870 | 5,730 | 5,800 | -20 | -0.3% | 553,800 |
| 2019/07/02 | 5,730 | 5,850 | 5,710 | 5,820 | +120 | +2.1% | 643,400 |
| 2019/07/01 | 5,640 | 5,720 | 5,580 | 5,700 | +190 | +3.4% | 657,500 |
| 2019/06/28 | 5,400 | 5,520 | 5,380 | 5,510 | +150 | +2.8% | 748,900 |
| 2019/06/27 | 5,350 | 5,360 | 5,250 | 5,360 | -20 | -0.4% | 475,000 |
| 2019/06/26 | 5,400 | 5,450 | 5,360 | 5,380 | -70 | -1.3% | 438,000 |
| 2019/06/25 | 5,450 | 5,540 | 5,420 | 5,450 | -40 | -0.7% | 411,400 |
| 2019/06/24 | 5,380 | 5,520 | 5,370 | 5,490 | +110 | +2% | 490,800 |
| 2019/06/21 | 5,680 | 5,690 | 5,340 | 5,380 | -260 | -4.6% | 1,049,300 |
| 2019/06/20 | 5,650 | 5,730 | 5,620 | 5,640 | +30 | +0.5% | 624,600 |
| 2019/06/19 | 5,630 | 5,630 | 5,550 | 5,610 | +70 | +1.3% | 594,800 |
| 2019/06/18 | 5,550 | 5,680 | 5,520 | 5,540 | -30 | -0.5% | 740,700 |
| 2019/06/17 | 5,740 | 5,760 | 5,550 | 5,570 | -190 | -3.3% | 805,500 |
| 2019/06/14 | 5,700 | 5,760 | 5,650 | 5,760 | +40 | +0.7% | 517,400 |
| 2019/06/13 | 5,780 | 5,810 | 5,680 | 5,720 | -80 | -1.4% | 676,200 |
| 2019/06/12 | 5,870 | 5,900 | 5,800 | 5,800 | -90 | -1.5% | 563,800 |
| 2019/06/11 | 5,830 | 5,890 | 5,800 | 5,890 | +10 | +0.2% | 625,300 |
| 2019/06/10 | 5,830 | 5,880 | 5,780 | 5,880 | +140 | +2.4% | 575,200 |
| 2019/06/07 | 5,700 | 5,780 | 5,650 | 5,740 | +110 | +2% | 740,300 |
| 2019/06/06 | 5,530 | 5,640 | 5,500 | 5,630 | +140 | +2.6% | 901,500 |
| 2019/06/05 | 5,370 | 5,520 | 5,360 | 5,490 | +280 | +5.4% | 827,100 |
| 2019/06/04 | 5,350 | 5,400 | 5,180 | 5,210 | -130 | -2.4% | 607,100 |
| 2019/06/03 | 5,300 | 5,390 | 5,270 | 5,340 | -70 | -1.3% | 600,400 |
| 2019/05/31 | 5,300 | 5,450 | 5,300 | 5,410 | +80 | +1.5% | 800,500 |
| 2019/05/30 | 5,420 | 5,420 | 5,230 | 5,330 | -70 | -1.3% | 837,900 |
| 2019/05/29 | 5,440 | 5,470 | 5,330 | 5,400 | -100 | -1.8% | 895,600 |
| 2019/05/28 | 5,520 | 5,580 | 5,360 | 5,500 | +170 | +3.2% | 6,640,000 |
| 2019/05/27 | 5,260 | 5,340 | 5,170 | 5,330 | +30 | +0.6% | 903,200 |
| 2019/05/24 | 5,440 | 5,500 | 5,270 | 5,300 | -210 | -3.8% | 1,009,400 |
| 2019/05/23 | 5,500 | 5,530 | 5,450 | 5,510 | +70 | +1.3% | 764,200 |
| 2019/05/22 | 5,500 | 5,600 | 5,430 | 5,440 | ±0 | ±0% | 785,000 |
| 2019/05/21 | 5,460 | 5,550 | 5,390 | 5,440 | -70 | -1.3% | 888,500 |
| 2019/05/20 | 5,660 | 5,730 | 5,510 | 5,510 | -190 | -3.3% | 749,200 |
| 2019/05/17 | 5,760 | 5,790 | 5,640 | 5,700 | +40 | +0.7% | 728,600 |
| 2019/05/16 | 5,590 | 5,710 | 5,560 | 5,660 | +100 | +1.8% | 818,800 |
| 2019/05/15 | 5,740 | 5,740 | 5,560 | 5,560 | -10 | -0.2% | 1,007,900 |
1501～
1550
件表示中 / 2997件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ペプチド | 168,700円 | +5.0% | +1.5% | 0.00% | 14.44倍 | 4.06倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| サワイＧＨＤ | 202,900円 | +5.9% | +684.6% | 2.71% | 13.47倍 | 1.34倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| 日本新薬 | 329,700円 | +3.6% | -15.3% | 3.76% | 9.25倍 | 0.90倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| キッセイ薬 | 452,500円 | +3.6% | - | 2.65% | 15.25倍 | 0.90倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 科研薬 | 389,200円 | -6.4% | -71.8% | 4.88% | 43.34倍 | 0.97倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム
